In order to determine the sensitivity of our assay to detect neuroblastoma cells, we created serial dilutions of 1.25%, 2.5%, and 5% neuroblastoma cells in PBMC and detected the CD45−/HSAN+ population in each cell mixture (Figure 3A). This evidence concerns the gene NAA50 and neuroblastoma.